Effect of the Membrane Blue Dual® Dye on the Retinal Sensitivity in Macular Hole Surgery
MICROCOL
Pilot Study of the Effect on the Retinal Sensitivity of the Membrane Blue Dual® Dye Used for Peeling of the Internal Limiting Membrane in Macular Hole Surgery
1 other identifier
observational
34
1 country
2
Brief Summary
The idiopathic macular hole, age-related disease, is a major cause of vision loss and affects at least two persons in 1000 after 40 years. This hole causes an acute decline linked to a central scotoma. The only treatment is surgical. The surgery involves removing the posterior hyaloid (vitreous base) to relieve the tensile forces. To be sure the removed is complete and to facilitate the closure of the hole, a peeling of the internal limiting, the outermost layer of the retina, is often suggested. The inner limiting membrane (ILM), transparent and adherent to the retina, is colored with vital dyes to facilitate its removal. After closure of the macular hole, the central scotoma disappears but a diffuse and asymptomatic loss of pericentral sensitivity is often described. This sensitivity decrease could be induced by the dyes used during surgery. This effect has not been studied clinically for recent dyes (Membrane Blue Dual®, Brilliant Blue®, Acid Violet®) at the concentrations used, but is known in electrophysiology at higher concentrations, at least on the isolated retina models. It would be interesting to search for a decrease in retinal peri-foveal postoperative sensitivity after surgery of macular holes, performed with the usual dyes. Only microperimetry can observe this decrease in retinal sensitivity. This is a noninvasive technique that explores the macular visual field. It is performed without iris dilatation and allows an automatic exploration ensuring rapid and accurate analysis of retinal sensitivity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2017
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2016
CompletedFirst Posted
Study publicly available on registry
September 9, 2016
CompletedStudy Start
First participant enrolled
February 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2021
CompletedOctober 6, 2021
October 1, 2021
4 years
September 5, 2016
October 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in retinal sensitivity
change from baseline sensitivity at 1 month after macular hole surgery
change from baseline sensitivity at 1 month after macular hole surgery
Eligibility Criteria
Patients referred for macular hole surgery
You may qualify if:
- age ≥ 18 years
- lower idiopathic macular hole inferior or equal to 600 micron millimeter
- undergoing macular hole surgery
You may not qualify if:
- Myopia \> -3 diopters
- pregnant women
- no Health Insurance coverage
- refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU Dijon
Dijon, France
Fondation Ophtalmologique A. de Rotchschild
Paris, 75019, France
Study Officials
- PRINCIPAL INVESTIGATOR
Yannick Le Mer, MD
Fondation OPH A de Rothschild
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2016
First Posted
September 9, 2016
Study Start
February 23, 2017
Primary Completion
February 23, 2021
Study Completion
October 5, 2021
Last Updated
October 6, 2021
Record last verified: 2021-10